Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial.
about
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysisShort-acting erythropoiesis-stimulating agents for anaemia in predialysis patientsRecombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patientsAssessing the Validity of Surrogate Outcomes for ESRD: A Meta-AnalysisHemoglobin targets for chronic kidney disease patients with anemia: a systematic review and meta-analysisThe cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizationsEvery-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: post hoc subanalysis of data from two clinical trials.The role of anemia management in improving outcomes for African-Americans with chronic kidney diseaseLeveraging practice-based research networks to accelerate implementation and diffusion of chronic kidney disease guidelines in primary care practices: a prospective cohort study.Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trialRecognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitusChronic kidney disease: a public health problem that needs a public health action planScreening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.Progression of glomerular and tubular disease in pediatrics.Renal resistive index as an indicator of the presence and severity of anemia and its future development in patients with hypertensionNew insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.Erythropoiesis stimulating agents and reno-protection: a meta-analysisTreating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendationsTherapeutic strategies to slow chronic kidney disease progression.Erythropoietin update 2011Novel renoprotective actions of erythropoietin: new uses for an old hormone.Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis ratsMechanisms of disease: erythropoietin--an old hormone with a new mission?Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?Renal anaemia: recent developments, innovative approaches and future directions for improved management.Renoprotective effect of curcumin against the combined oxidative stress of diabetes and nicotine in rats.Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection.Blind Pew sends a black spot: the current haemoglobin controversy.Economic burden of chronic kidney disease.Community-based study on CKD subjects and the associated risk factors.Anemia, diabetes, and chronic kidney disease.Comparative study of intravenous iron versus intravenous ascorbic Acid for treatment of functional iron deficiency in patients under hemodialysis: a randomized clinical trial.Dual inhibiting senescence and epithelial-to-mesenchymal transition by erythropoietin preserve tubular epithelial cell regeneration and ameliorate renal fibrosis in unilateral ureteral obstruction.A prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study.Restricted Use of Erythropoiesis-Stimulating Agent is Safe and Associated with Deferred Dialysis Initiation in Stage 5 Chronic Kidney Disease.Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis.Educational paper: Progression in chronic kidney disease and prevention strategies.The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection.Preventing the progression of chronic kidney disease: two case reports and review of the literature.
P2860
Q24187413-46DC92D9-1E41-47DB-A48D-766B6612333CQ24188190-89D35D1D-5C31-4569-9FAA-1043743401D1Q24246372-BE2D73A8-3DFC-448D-A91C-0443B2A62214Q26863404-C2B51132-6011-40C5-8B0D-1C6F60598550Q27023213-089E34B9-4AC4-46AE-9281-60A78B1A45B9Q28208693-D44DBE50-B5E7-41A6-BE28-D55C43EA61B2Q33494136-2EF13F26-AF8A-4016-A8B7-1B8D8A0E61F5Q33646679-A3886FAE-253A-4324-834A-F901EF657101Q34579290-E9BF77FA-562A-4CA7-9E79-AE799CA95F8DQ34800472-19B82E45-144D-4046-9748-F4CDFAED3D43Q34887952-BFE65447-2026-4427-98DA-0C4704612D77Q35024506-4B358A2D-BE43-4A65-A2CE-3EFA484B4835Q35148118-0D3E8C68-AD38-4E99-B66A-20B524E9DD0AQ35234337-6B4A3FFC-AD5E-48E0-85CC-1D70A52C0F71Q35368783-48FA0129-D639-47B8-8A32-87E4C255F776Q35988000-24E28BC1-0660-49CB-B3AB-B12C581E105CQ36128396-80C698D5-C333-40C8-8832-42B1395D87C5Q36246631-BE32A8C4-76B7-414F-910D-ACC370337C00Q36285948-AB75767E-7D5A-4CE2-9C41-994AEF030B36Q36510669-1DFE5D8A-1167-4877-BB62-21EC6AED90ECQ36516298-F5FB9AF6-A98C-4210-936C-DCC44F32A80EQ36556717-E378CCF5-2A5B-48A3-ABDB-4B9A05BE8B97Q36597896-C6730BE7-3070-4A65-B600-FA44716DA3E0Q36600985-326C4F2B-2FBF-4DCB-BD1F-96A53713FFB7Q36679596-6CB8F850-9319-4441-ADE9-552B33B083EEQ36697772-E97C0D96-F79C-4345-B30D-AEF03B25FF91Q36722222-11B856D1-7AF7-401E-9530-925C5702E0EBQ36736723-2C0050A2-7735-45A1-AAEC-678EEF970D42Q37053428-71EA887E-54C4-498F-A5C5-F42B337FAB4AQ37121836-83AB4F3E-32FE-4A26-BBA2-0E990813B7A9Q37231746-40482093-4A0C-468F-9535-6512C8EE868EQ37235968-A7FD162B-71AE-4241-B1EE-A12BD9868800Q37347851-BCF46C59-E4A2-48FE-98A3-C13A3ECE0864Q37367044-C99D1049-E1C6-416D-89B0-EE7DDB88888DQ37452708-E51AA6BB-088E-4472-ACC9-A6448B87B07EQ37685792-A5284F7C-38F5-4ABB-ADC1-51AFF68C5B04Q37953963-0B70CCC1-DFCE-411C-B284-7B389AAF7921Q38042582-FA0D271F-9B60-45C2-A9FD-85B74CC93B9AQ38123004-A217E3D9-EAD8-44E1-A956-ECB83CB4162FQ38221804-2F4DEC1D-5811-4260-A8D7-B6309FFA85CF
P2860
Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Treating anemia early in renal ...... a randomized controlled trial.
@en
Treating anemia early in renal ...... a randomized controlled trial.
@nl
type
label
Treating anemia early in renal ...... a randomized controlled trial.
@en
Treating anemia early in renal ...... a randomized controlled trial.
@nl
prefLabel
Treating anemia early in renal ...... a randomized controlled trial.
@en
Treating anemia early in renal ...... a randomized controlled trial.
@nl
P2093
P1433
P1476
Treating anemia early in renal ...... a randomized controlled trial.
@en
P2093
Chariclia Gouva
Kostas C Siamopoulos
Petros Nikolopoulos
P304
P356
10.1111/J.1523-1755.2004.00797.X
P407
P577
2004-08-01T00:00:00Z
P5875
P6179
1001364932